Ami Sabharwal
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- PARP inhibition in cancer therapy
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 6
-
- Cancer therapeutics and mechanisms 4
- Epigenetics and DNA Methylation 2
- Co-authors
- Rachel Kerr (1 shared paper)Mark R. Middleton (6 shared papers)Amanda J. Watson (6 shared papers)Geoffrey P. Margison (5 shared papers)Peter G. Mortimer (4 shared papers)Jane Beith (2 shared papers)Andrew Haydon (2 shared papers)Malcolm Ranson (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancers (1 paper)British Journal of Cancer (1 paper)Melanoma Research (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomAustralia
In The Last Decade
Ami Sabharwal
14 papers receiving 264 citations
Peers
Comparison fields: 5 of 44
- Genetics 92
- Oncology 112
- Cancer Research 45
- Molecular Biology 183
- Hematology 15
Countries citing papers authored by Ami Sabharwal
This map shows the geographic impact of Ami Sabharwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Sabharwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Sabharwal more than expected).
Fields of papers citing papers by Ami Sabharwal
This network shows the impact of papers produced by Ami Sabharwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Sabharwal. The network helps show where Ami Sabharwal may publish in the future.
Co-authors
The 25 scholars most cited alongside Ami Sabharwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 76 | |
| 2 | 2006 | 73 | |
| 3 | 2009 | 32 | |
| 4 | 2007 | 24 | |
| 5 | 2010 | 23 | |
| 6 | 2010 | 18 | |
| 7 | 2009 | 13 | |
| 8 | 2024 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2014 | 1 | |
| 11 | 2008 | 1 | |
| 12 | Pancreatic ascites due to Hodgkin's lymphoma pancreas. | 1983 | 1 |
| 13 | 2020 | 1 | |
| 14 | 2007 | 1 |
About Ami Sabharwal
Ami Sabharwal is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 14 papers that have together received 266 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Epigenetics and DNA Methylation (2 papers), Advanced Radiotherapy Techniques (1 paper), Prostate Cancer Treatment and Research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Genetics (92 citations), Oncology (112 citations), Cancer Research (45 citations), Molecular Biology (183 citations) and Hematology (15 citations). Ami Sabharwal has collaborated with scholars based in United Kingdom and Australia. Frequent co-authors include Rachel Kerr, Mark R. Middleton, Amanda J. Watson, Geoffrey P. Margison, Peter G. Mortimer, Jane Beith, Andrew Haydon, Malcolm Ranson, Peter Hersey and Ian D. Davis. Their work appears in journals such as Journal of Clinical Oncology, Cancers, British Journal of Cancer, Melanoma Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.